ATE456050T1 - Verfahren zum nachweis von bei rheumatoider arthritis gebildeten autoantikörpern - Google Patents

Verfahren zum nachweis von bei rheumatoider arthritis gebildeten autoantikörpern

Info

Publication number
ATE456050T1
ATE456050T1 AT06778497T AT06778497T ATE456050T1 AT E456050 T1 ATE456050 T1 AT E456050T1 AT 06778497 T AT06778497 T AT 06778497T AT 06778497 T AT06778497 T AT 06778497T AT E456050 T1 ATE456050 T1 AT E456050T1
Authority
AT
Austria
Prior art keywords
rheumatoid arthritis
type
collagen
detecting autoantibodies
alpha1
Prior art date
Application number
AT06778497T
Other languages
English (en)
Inventor
Marja-Kaisa Koivula
Juha Risteli
Original Assignee
Procollagen Oy
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Procollagen Oy filed Critical Procollagen Oy
Application granted granted Critical
Publication of ATE456050T1 publication Critical patent/ATE456050T1/de

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/564—Immunoassay; Biospecific binding assay; Materials therefor for pre-existing immune complex or autoimmune disease, i.e. systemic lupus erythematosus, rheumatoid arthritis, multiple sclerosis, rheumatoid factors or complement components C1-C9
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/78—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin, cold insoluble globulin [CIG]
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/10—Musculoskeletal or connective tissue disorders
    • G01N2800/101—Diffuse connective tissue disease, e.g. Sjögren, Wegener's granulomatosis
    • G01N2800/102—Arthritis; Rheumatoid arthritis, i.e. inflammation of peripheral joints
AT06778497T 2005-08-11 2006-08-10 Verfahren zum nachweis von bei rheumatoider arthritis gebildeten autoantikörpern ATE456050T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FI20050814A FI20050814A0 (fi) 2005-08-11 2005-08-11 Menetelmä nivelreumassa muodostuvien kollageeniautovasta-aineiden havaitsemiseksi
PCT/FI2006/000275 WO2007017556A1 (en) 2005-08-11 2006-08-10 Method for detecting autoantibodies formed in rheumatoid arthritis

Publications (1)

Publication Number Publication Date
ATE456050T1 true ATE456050T1 (de) 2010-02-15

Family

ID=34896278

Family Applications (1)

Application Number Title Priority Date Filing Date
AT06778497T ATE456050T1 (de) 2005-08-11 2006-08-10 Verfahren zum nachweis von bei rheumatoider arthritis gebildeten autoantikörpern

Country Status (7)

Country Link
US (1) US20090325884A1 (de)
EP (1) EP1946109B1 (de)
JP (1) JP2009505049A (de)
AT (1) ATE456050T1 (de)
DE (1) DE602006011934D1 (de)
FI (1) FI20050814A0 (de)
WO (1) WO2007017556A1 (de)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0708585D0 (en) 2007-05-03 2007-06-13 Queen Mary & Westfield College Novel antibody and use in diagnosis and therapy of arthropathies
EP2058663A1 (de) * 2007-11-12 2009-05-13 Euro-Diagnostica B.V. Verfahren zur Immobilisierung eines Analyts auf einem festen Träger
ES2584438T3 (es) 2008-03-21 2016-09-27 Universiteit Hasselt Biomarcadores para artritis reumatoide
EP2325195A1 (de) 2009-11-23 2011-05-25 Toscana Biomarkers S.r.l. Virale citrullinierte Peptide und Verwendungen dafür
EP2402368A1 (de) 2010-07-02 2012-01-04 Toscana Biomarkers S.r.l. Histoncitrullinierte Peptide und deren Verwendungen
CN108117586A (zh) 2010-08-10 2018-06-05 洛桑聚合联合学院 红细胞结合性治疗剂
US9517257B2 (en) 2010-08-10 2016-12-13 Ecole Polytechnique Federale De Lausanne (Epfl) Erythrocyte-binding therapeutics
US9850296B2 (en) 2010-08-10 2017-12-26 Ecole Polytechnique Federale De Lausanne (Epfl) Erythrocyte-binding therapeutics
EP3412680B1 (de) 2011-04-05 2020-11-04 Curara AB Neuartige peptide zur bindung an einzelne typen der mhc-klasse-ii und deren verwendung in diagnose und behandlung
EP2527841A1 (de) 2011-05-25 2012-11-28 Toscana Biomarkers S.r.l. Verfahren zur Diagnose rheumatoider Arthritis
GB201302036D0 (en) * 2013-02-05 2013-03-20 Queen Mary & Westfield College Diagnosis
US10953101B2 (en) 2014-02-21 2021-03-23 École Polytechnique Fédérale De Lausanne (Epfl) Glycotargeting therapeutics
US10946079B2 (en) 2014-02-21 2021-03-16 Ecole Polytechnique Federale De Lausanne Glycotargeting therapeutics
JP6744227B2 (ja) 2014-02-21 2020-08-19 エコール・ポリテクニーク・フェデラル・ドゥ・ローザンヌ（ウペエフエル）Ｅｃｏｌｅ Ｐｏｌｙｔｅｃｈｎｉｑｕｅ Ｆｅｄｅｒａｌｅ ｄｅ Ｌａｕｓａｎｎｅ （ＥＰＦＬ） 糖標的化治療剤
US10046056B2 (en) 2014-02-21 2018-08-14 École Polytechnique Fédérale De Lausanne (Epfl) Glycotargeting therapeutics
WO2018232176A1 (en) 2017-06-16 2018-12-20 The University Of Chicago Compositions and methods for inducing immune tolerance
WO2019165436A1 (en) 2018-02-26 2019-08-29 Antolrx Tolerogenic liposomes and methods of use thereof
CN111868073B (zh) * 2019-05-31 2021-04-30 广州市雷德生物科技有限公司 一种类风湿关节炎相关的特异性多肽及其应用
CN110456074B (zh) * 2019-08-27 2022-06-03 广东菲鹏生物有限公司 瓜氨酸肽及其应用、类风湿关节炎的检测试剂与试剂盒
EP4317172A1 (de) * 2021-03-24 2024-02-07 Sekisui Medical Co., Ltd. Immunologisches analyseverfahren für typ-i-kollagen-c-terminales tlopeptid
CN113109574A (zh) * 2021-04-15 2021-07-13 北京森美希克玛生物科技有限公司 检测抗突变型瓜氨酸化波形蛋白抗体的试剂盒以及检测方法
CN113917135A (zh) * 2021-10-18 2022-01-11 北京和杰创新生物医学科技有限公司 抗角蛋白抗体的免疫球蛋白g的检测方法

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3513915A1 (de) * 1985-04-17 1986-10-23 Heyl Chemisch-pharmazeutische Fabrik GmbH & Co KG, 1000 Berlin Immunologischer testkit
DK104093D0 (da) * 1993-09-17 1993-09-17 Osteometer A S Fremgangsmaade til bestemmelse af collagen-fragmenter i legemsvaesker, test-kit og midler til udoevelse af fremgangsmaaden og anvendelse af fremgangsmaaden til diagnosticering af lidelser associeret til collagen-metabolismen
JP2003502672A (ja) * 1999-06-17 2003-01-21 ワシントン リサーチ ファンデーション 軟骨吸収アッセイ
WO2003032909A2 (en) * 2001-10-18 2003-04-24 Ilex Products, Inc. Methods of treating skin with diphosphonate derivatives
NL1019540C2 (nl) * 2001-12-11 2003-07-01 Stichting Tech Wetenschapp Werkwijze voor het detecteren van auto-antilichamen van patienten die lijden aan reumatoïde artritis, peptide en assaykit.
EP1483399B1 (de) * 2002-02-12 2008-10-29 The Regents of the University of California Nichtinvasive messung der biosynthese- und abbaugeschwindigkeiten biologischer moleküle, die einer direkten probenahme unzugänglich oder nicht leicht zugänglich sind, durch einbau einer markierung in metabolische derivate und katabole produkte
EP1578776A4 (de) * 2002-09-30 2007-11-07 Shriners Hospitals Children Produkte zur regulierung des abbaus voncollagen und verfahren zu deren identifizierung
US8198401B2 (en) * 2003-03-07 2012-06-12 London Health Sciences Centre Research Inc. Peptides associated with HLA-DR MHC class II molecule and involved in rheumatoid arthritis
ITTO20030246A1 (it) * 2003-03-31 2004-10-01 Univ Pisa Nuovi peptidi sintetici citrullinati e loro usi.
ES2297521T3 (es) * 2003-12-23 2008-05-01 F. Hoffmann-La Roche Ag Metodo para la evaluacion de la artritis reumatoide mediante la medicion de anti-pcc e interleuquina 6.
JP2006133177A (ja) * 2004-11-09 2006-05-25 Institute Of Physical & Chemical Research 関節リウマチの診断および治療におけるシトルリン化アンチトロンビン３の利用

Also Published As

Publication number Publication date
EP1946109A1 (de) 2008-07-23
JP2009505049A (ja) 2009-02-05
DE602006011934D1 (de) 2010-03-11
FI20050814A0 (fi) 2005-08-11
WO2007017556A1 (en) 2007-02-15
EP1946109B1 (de) 2010-01-20
US20090325884A1 (en) 2009-12-31

Similar Documents

Publication Publication Date Title
ATE456050T1 (de) Verfahren zum nachweis von bei rheumatoider arthritis gebildeten autoantikörpern
CY1117784T1 (el) Μεθοδοι και συνθεσεις για διαγνωση και προγνωση νεφρικης βλαβης και νεφρικης ανεπαρκειας
ATE450547T1 (de) Eml4-alk-fusionsgen
DE60334664D1 (de) System und Verfahren zum Nachweis von biologischem und chemischem Material
BRPI0618713B8 (pt) cardiolipina modificada e seus usos
DE502005006434D1 (de) Vorrichtung und verfahren zum nachweis von geladenen makromolekülen
DE602005008277D1 (de) Von fibrin abgeleitete citrullinpeptide, die durch für rheumatoide arthritis spezifische autoantikörper erkannt werden, und deren verwendung
ATE554106T1 (de) Antikörper für onkogene stämme von hpv und verfahren zu deren verwendung
ATE514950T1 (de) Verfahren zur untersuchung von sepsis bei menschen
MX2011008323A (es) Metodos y composiciones para diagnosis y prognosis de lesion renal y falla renal.
ATE292801T1 (de) Verfahren zum screening von inhibitoren von asp2
CY1108568T1 (el) Αναστολεας για διαγνωση και θεραπεια ασθενων με αιμορροφιλια α
DE60314955D1 (de) Verfahren zur Inspektion von Dampfturbinen
DE60301801D1 (de) Elektrochemischer Sensor zum Nachweis von Kohlenmonoxid
DE60321356D1 (de) Verfahren zur diagnostik von eierstock endometriose
ATE532072T1 (de) Verfahren und vorrichtung zur beurteilung von polypeptidaggregation
DE60325382D1 (de) Verfahren zur diagnose von gebärmutterhalskrebs
ATE475098T1 (de) Verfahren zur messung von plasmaspiegeln von pentraxin ptx3
DE602004023824D1 (de) Verfahren zum direkten nachweis einzelner methotrexatmetabolite
ATE333521T1 (de) Detektion von vancomycin-resistenten enterococcus-subspezies
ATE534669T1 (de) Verfahren zum erhalten von anti-idiotyp antikörpern
DE502005005957D1 (de) Verfahren zum anaeroben biologischen abbau von organosiloxanen
BR0303012A (pt) Avaliação de câncer colorretal
BR0303091A (pt) Avaliação de câncer colorretal
WO2004029622A3 (en) Antibody tools for the diagnostic use in the medical therapy with inhibitors of histone deacetylases

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties